HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Domschke Selected Research

Interleukin-10 (Interleukin 10)

7/2008The role of interleukin-10 promoter polymorphisms in primary Sjogren's syndrome.
3/2007Clinical and immunological characteristics of patients with Sjögren's syndrome in relation to alpha-fodrin antibodies.
4/2005Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis.
11/2004Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Domschke Research Topics

Disease

7Ulcer
03/2009 - 08/2000
7Neoplasms (Cancer)
07/2008 - 10/2002
7Necrosis
03/2007 - 09/2000
6Infections
12/2006 - 01/2001
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2005 - 01/2001
5Pancreatitis
04/2011 - 09/2000
5Inflammation (Inflammations)
10/2006 - 02/2000
4Disease Susceptibility (Diathesis)
07/2008 - 04/2001
3Ulcerative Colitis
12/2013 - 04/2001
3Carcinoma (Carcinomatosis)
12/2006 - 01/2000
3Rheumatoid Arthritis
05/2005 - 08/2004
3Pathologic Constriction (Stenosis)
05/2004 - 01/2000
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2003 - 07/2000
3Stomach Ulcer (Gastric Ulcer)
03/2003 - 06/2001
3Acute Liver Failure (Fulminant Hepatic Failure)
12/2001 - 02/2000
2Hepatocellular Carcinoma (Hepatoma)
04/2018 - 12/2006
2Chronic Pancreatitis
08/2008 - 11/2000
2Liver Diseases (Liver Disease)
07/2008 - 05/2005
2Pain (Aches)
12/2007 - 06/2001
2Colitis
10/2006 - 07/2000
2Adenocarcinoma
09/2006 - 02/2000
2Stomach Neoplasms (Stomach Cancer)
09/2006 - 06/2006
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
05/2005 - 11/2001
2Lymphoma (Lymphomas)
05/2005 - 11/2001
2Rupture
05/2005 - 02/2002
2Gastroparesis
01/2005 - 01/2002
2Hemorrhage
10/2004 - 02/2002
2Chronic Hepatitis C
12/2002 - 10/2001
2Brain Diseases (Brain Disorder)
12/2001 - 09/2001
2Duodenal Ulcer (Curling's Ulcer)
03/2001 - 11/2000
1Liver Neoplasms (Liver Cancer)
04/2018
1Portal Hypertension
04/2018
1Hepatitis
04/2018
1End Stage Liver Disease
04/2018
1Abdominal Pain (Pain, Abdominal)
04/2011
1Mixed Connective Tissue Disease (MCTD)
03/2009
1Skin Ulcer
03/2009
1Leg Ulcer
03/2009
1Pulmonary Arterial Hypertension
03/2009
1Connective Tissue Diseases (Connective Tissue Disease)
03/2009
1Adult-Onset Still's Disease
01/2009
1Graft vs Host Disease (Graft-Versus-Host Disease)
09/2008
1Hereditary pancreatitis
08/2008
1Sjogren's Syndrome (Sjogren Syndrome)
07/2008
1Hepatitis B
12/2006
1Weight Loss (Weight Reduction)
10/2006

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
08/2008 - 03/2001
5Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2006 - 03/2001
5CytokinesIBA
08/2004 - 06/2001
4TrypsinogenIBA
10/2010 - 09/2000
4Interleukin-10 (Interleukin 10)IBA
07/2008 - 11/2004
4Interferon-gamma (Interferon, gamma)IBA
03/2007 - 01/2001
3BilirubinIBA
04/2011 - 09/2001
3TrypsinIBA
10/2010 - 09/2000
3InterleukinsIBA
03/2007 - 05/2004
3ErbB Receptors (EGF Receptor)IBA
09/2006 - 01/2001
3Etanercept (Enbrel)FDA Link
05/2005 - 08/2004
3Pharmaceutical PreparationsIBA
01/2005 - 06/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2004 - 11/2001
3Interleukin-6 (Interleukin 6)IBA
01/2004 - 04/2001
3Messenger RNA (mRNA)IBA
03/2003 - 01/2001
3Acetic Acid (Vinegar)FDA LinkGeneric
03/2003 - 06/2001
2Capsules (Microcapsules)IBA
12/2013 - 09/2008
2Lipase (Acid Lipase)FDA Link
04/2011 - 09/2000
2Peptide Hydrolases (Proteases)FDA Link
10/2010 - 09/2000
2CeruletideIBA
10/2010 - 10/2005
2Cathepsin BIBA
10/2010 - 09/2000
2AmylasesFDA Link
10/2010 - 09/2000
2AutoantibodiesIBA
07/2008 - 01/2003
2Gefitinib (Iressa)FDA Link
09/2006 - 06/2006
2Insulin (Novolin)FDA Link
01/2005 - 11/2000
2Biological ProductsIBA
10/2004 - 05/2001
2Indomethacin (Indometacin)FDA LinkGeneric
05/2004 - 02/2000
2Interleukin-1beta (Interleukin 1 beta)IBA
01/2004 - 04/2003
2DNA (Deoxyribonucleic Acid)IBA
01/2003 - 04/2001
2SteroidsIBA
11/2001 - 07/2000
2CaspasesIBA
11/2001 - 10/2001
2Proton Pump InhibitorsIBA
11/2000 - 08/2000
1Analgesics (Analgesic Drugs)IBA
04/2011
1Mannose (D-Mannose)IBA
10/2010
1CationsIBA
10/2010
1Phosphates (Orthophosphate)IBA
10/2010
1IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)IBA
10/2010
1Endothelin A ReceptorIBA
03/2009
1sitaxsentanIBA
03/2009
1Iloprost (Ventavis)FDA Link
03/2009
1Macrophage Migration-Inhibitory FactorsIBA
01/2009
1Carbon DioxideIBA
12/2007
1Antiviral Agents (Antivirals)IBA
12/2006
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
12/2006
1alpha-MSHIBA
10/2006
1Melanocortin Receptors (Melanocortin Receptor)IBA
10/2006

Therapy/Procedure

13Therapeutics
12/2006 - 08/2000
4Liver Transplantation
12/2001 - 02/2000
2Endoscopes
05/2004 - 01/2000
2Parenteral Nutrition
01/2002 - 11/2000
1Surgical Portasystemic Shunt (Portosystemic Shunt)
04/2018
1Length of Stay
04/2011
1Palliative Care (Palliative Therapy)
07/2008
1Drug Therapy (Chemotherapy)
12/2006